secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-01-03T23:59:59+00:00
Accession:  0001104659-24-000958
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS Life Sciences terminates $50M ATM sales agreement with Cantor Fitzgerald
-------------------------------------------------------------------------------

- Mutual termination of Controlled Equity Offering Sales Agreement dated April 16, 2021.
- ATM program allowed up to $50M in common stock sales; prior termination, 1,294,814 shares sold for ~$10.5M net.
- Related prospectus supplement filed in 2021 also terminated effective immediately.
- Company may explore alternative financing options going forward.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924000958/0001104659-24-000958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924000958/tm241849d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-000958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer